SI and the new CEO (whoever that may be?) have one thing in common:
Neither have commercialized stem cells or been granted FDA approval for stem cells. One of the two has been trying for decades.
Here's a thought......
What if they found a CEO that has taken a novel drug to market and achieved commercialization? Wild thinking!!!
In 2020 & 2021 over 100 products were given FDA approval and 5 have been given approval so far in 2022. Yes, most are big pharma but not all. Some people/companies navigated the FDA minefield and got the flag. Others ran as fast as they could straight at the flag and got blown to pieces.
Those same people (mostly, RIP Fred) are taking a run up to take it on again?
SI crows about how experienced the MSB team is yet I don't see a lot of recent experience in successful FDA approval getting? That is not important?
SI and the new CEO (whoever that may be?) have one thing in...
-
- There are more pages in this discussion • 654 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 122380 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 11015 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |